A Research Study to Evaluate the Safety of NNC4004-0002 When Given to Participants With Asymptomatic Hyperuricemia
Clinical trial NCT06859073 · RECRUITING
Trial details
- NCT number
- NCT06859073
- Sponsor
- Novo Nordisk A/S
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-11-13
- Primary completion
- 2026-06-01
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.